Image description

European Gram Negative AntiBacterial Engine

ENABLE

WHO ARE WE?


The whole consortium is managed by a Consortium Management Office and especifically:


Project coordinator

  • Neil Pearson, GlaxoSmithKline Research and Development Ltd (Neil.Pearson@gsk.com)


Managing entity

  • Anders KarlĂ©n, Uppsala University (Anders.Karlen@orgfarm.uu.se)


ENABLE is a European-based consortium:
Click on the map to view the list of partners and their official websites

HOW DO WE WORK TOGETHER ? 


The ENABLE project has created and is currently managing a drug discovery platform. 

This platform consists of dedicated teams who pool their resources for the testing and optimization of molecules.


Resource allocation to programmes is managed by the Implementation Committee.


The Consortium Management Office supports all above governing and is responsible for the overall project management as well as communication with the Innovative Medicines Initiatives office.

 

The Portfolio Management Committee (PMC) is the body in charge of ensuring the prosperity of ENABLE portfolio. 

It is responsible for reviewing and approving the entry of new programmes into the portfolio. 

To learn more one the Open Call Process, please click here.


In addition the PMC determines quarterly whether programmes may continue activity in ENABLE and when to proceed to the successive development steps


To learn more about our portfolio, please click here.